Jun‐Kui Li

469 total citations
16 papers, 334 citations indexed

About

Jun‐Kui Li is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Jun‐Kui Li has authored 16 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Jun‐Kui Li's work include Cytokine Signaling Pathways and Interactions (5 papers), Natural product bioactivities and synthesis (3 papers) and Autophagy in Disease and Therapy (3 papers). Jun‐Kui Li is often cited by papers focused on Cytokine Signaling Pathways and Interactions (5 papers), Natural product bioactivities and synthesis (3 papers) and Autophagy in Disease and Therapy (3 papers). Jun‐Kui Li collaborates with scholars based in Hong Kong and China. Jun‐Kui Li's co-authors include Peili Zhu, Xiu‐Qiong Fu, Cheng‐Le Yin, Zhi‐Ling Yu, Ji‐Yao Chou, Ying‐Jie Chen, Jing‐Xuan Bai, Jia‐Ying Wu, Ying Wu and Yuxi Liu and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Ethnopharmacology.

In The Last Decade

Jun‐Kui Li

16 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun‐Kui Li Hong Kong 11 170 67 57 55 43 16 334
Hanchi Miao China 7 234 1.4× 48 0.7× 63 1.1× 49 0.9× 38 0.9× 7 345
Ji‐Yao Chou Hong Kong 13 213 1.3× 74 1.1× 68 1.2× 62 1.1× 68 1.6× 19 416
Bo‐Ram Jin South Korea 14 185 1.1× 37 0.6× 49 0.9× 40 0.7× 36 0.8× 41 442
Nianzhi Chen China 12 158 0.9× 44 0.7× 59 1.0× 33 0.6× 56 1.3× 22 365
Rongling Zhong China 11 208 1.2× 62 0.9× 46 0.8× 46 0.8× 104 2.4× 21 411
Fei Yao China 12 170 1.0× 60 0.9× 55 1.0× 32 0.6× 32 0.7× 20 360
Prakash Dharmalingam India 10 238 1.4× 53 0.8× 64 1.1× 28 0.5× 36 0.8× 11 417
Wanfu Lin China 12 175 1.0× 67 1.0× 40 0.7× 62 1.1× 45 1.0× 24 403
Zhongwen Luo China 10 267 1.6× 39 0.6× 52 0.9× 39 0.7× 40 0.9× 24 403
Thu‐Huyen Pham South Korea 11 203 1.2× 77 1.1× 37 0.6× 60 1.1× 39 0.9× 20 389

Countries citing papers authored by Jun‐Kui Li

Since Specialization
Citations

This map shows the geographic impact of Jun‐Kui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun‐Kui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun‐Kui Li more than expected).

Fields of papers citing papers by Jun‐Kui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun‐Kui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun‐Kui Li. The network helps show where Jun‐Kui Li may publish in the future.

Co-authorship network of co-authors of Jun‐Kui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jun‐Kui Li. A scholar is included among the top collaborators of Jun‐Kui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun‐Kui Li. Jun‐Kui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Li, Jun‐Kui, Xiaoli Jiang, Zhu Zhang, et al.. (2024). Isoalantolactone exerts anti‐melanoma effects via inhibiting PI3K/AKT/mTOR and STAT3 signaling in cell and mouse models. Phytotherapy Research. 38(6). 2800–2817. 9 indexed citations
2.
Li, Jun‐Kui, Xiaoli Jiang, Zhu Zhang, et al.. (2024). 20(S)-Ginsenoside Rh2 induces apoptosis and autophagy in melanoma cells via suppressing Src/STAT3 signaling. Journal of Ginseng Research. 48(6). 559–569. 4 indexed citations
3.
Zhu, Peili, Jun‐Kui Li, Xiaoli Jiang, et al.. (2023). A traditional prescription comprising Astragali Radix and Schisandra chinensis Fructus induces apoptosis and protective autophagy in hepatocellular carcinoma cells. Journal of Ethnopharmacology. 312. 116548–116548. 7 indexed citations
4.
Wu, Jia‐Ying, Ying‐Jie Chen, Xiu‐Qiong Fu, et al.. (2022). Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling. BMC Complementary Medicine and Therapies. 22(1). 73–73. 20 indexed citations
5.
Li, Jun‐Kui, Peili Zhu, Ying Wang, et al.. (2022). Gracillin exerts anti-melanoma effects in vitro and in vivo: role of DNA damage, apoptosis and autophagy. Phytomedicine. 108. 154526–154526. 14 indexed citations
6.
Li, Jun‐Kui, Haitao Sun, Xiaoli Jiang, et al.. (2022). Polyphyllin II Induces Protective Autophagy and Apoptosis via Inhibiting PI3K/AKT/mTOR and STAT3 Signaling in Colorectal Cancer Cells. International Journal of Molecular Sciences. 23(19). 11890–11890. 22 indexed citations
7.
Liu, Yuxi, Xiaodi Niu, Ying‐Jie Chen, et al.. (2021). Inhibition of Src/STAT3 signaling-mediated angiogenesis is involved in the anti-melanoma effects of dioscin. Pharmacological Research. 175. 105983–105983. 30 indexed citations
8.
Chen, Ying‐Jie, Yuxi Liu, Jia‐Ying Wu, et al.. (2021). A two-herb formula inhibits hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes. Scientific Reports. 11(1). 3850–3850. 8 indexed citations
9.
Wu, Jia‐Ying, Ying‐Jie Chen, Yuxi Liu, et al.. (2020). Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-κB and STAT3 pathways. Phytomedicine. 68. 153173–153173. 62 indexed citations
10.
Fu, Xiu‐Qiong, Bin Liu, Yaping Wang, et al.. (2020). Activation of STAT3 is a key event in TLR4 signaling-mediated melanoma progression. Cell Death and Disease. 11(4). 246–246. 55 indexed citations
11.
Chen, Ying‐Jie, Jia‐Ying Wu, Yuxi Liu, et al.. (2020). A two-herb formula inhibits osteoclastogenesis and suppresses NF-kB and MAPK pathways. Journal of Ethnopharmacology. 252. 112625–112625. 6 indexed citations
12.
Zhu, Peili, Jun‐Kui Li, Xiu‐Qiong Fu, et al.. (2020). Gomisin N Exerts Anti-liver Cancer Effects and Regulates PI3K–Akt and mTOR–ULK1 Pathways <i>in Vitro</i>. Biological and Pharmaceutical Bulletin. 43(8). 1267–1271. 13 indexed citations
13.
Chen, Ying‐Jie, Xiu‐Qiong Fu, Peili Zhu, et al.. (2020). Inhibiting the Src/STAT3 signaling pathway contributes to the anti‑melanoma mechanisms of dioscin. Oncology Letters. 19(3). 2508–2514. 12 indexed citations
14.
Liu, Yuxi, Jing‐Xuan Bai, Ting Li, et al.. (2019). MiR-let-7a/f-CCR7 signaling is involved in the anti-metastatic effects of an herbal formula comprising Sophorae Flos and Lonicerae Japonicae Flos in melanoma. Phytomedicine. 64. 153084–153084. 13 indexed citations
15.
Liu, Yuxi, Jing‐Xuan Bai, Ting Li, et al.. (2019). A TCM formula comprising Sophorae Flos and Lonicerae Japonicae Flos alters compositions of immune cells and molecules of the STAT3 pathway in melanoma microenvironment. Pharmacological Research. 142. 115–126. 38 indexed citations
16.
Zhu, Peili, Xiu‐Qiong Fu, Jun‐Kui Li, et al.. (2018). Antrodia camphorata Mycelia Exert Anti-liver Cancer Effects and Inhibit STAT3 Signaling in vitro and in vivo. Frontiers in Pharmacology. 9. 1449–1449. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026